Laurence Albiges presents “Emerging Biomarkers of VEGF and mTOR Inhibitors in 2015” at the 14th International Kidney Cancer Symposium.
Browsing: Acute Lymphoblastic Leukemia
Daniel Y C Heng MD MPH FRCPC of the University of Calgary presents “Improving Patient Care Through Health Outcome Research…
Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr…
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is…
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer…
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute,…
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada,…
Judge Schonfeld-CEO-CureHunter Inc. presents “Speeding Drug Discovery with Computational Biology Network Graph Theory” at the 14th International Kidney Cancer Symposium.
John A. Josey, Ph.D. Peloton Therapeutics, Inc. presents “Targeting HIF-2: Myth or Reality? A First-In-Class HIF-2 Antagonist for the Treatment…
Jeffrey Wallin, Ph.D. of Genentech presents “Opening the Floodgates to T Cells Biomarkers for the Combination of Bevacizumab and Atezolizumab…
Fabian Zohren, MD PhD from Takeda presents “Inhibiting the mTOR Complex: Biology and Targets” at the 14th International Kidney Cancer…
Mark W Ball presents “Pathologic and Genomic Profiles of Exceptional Responders to Anti-PD1 Therapy in Renal Cell Carcinoma” at the…
Toni Choueiri, MD Dana-Farber Cancer Institute presents “Phase Ib Dose-Finding Study of Axitinib Plus Pembrolizumab in Treatment-Naïve PatientsWith Advanced Renal…
Michael Postow, MD from Memorial Sloan Kettering Cancer Center presents “Managing Side Effects of Immune Checkpoint Blockade” at the 14th…
Dan George, MD Duke Cancer Institute presents “Oncolytic Viruses” at the 14th International Kidney Cancer Symposium.
David McDermott, MD of Dana Farber presents “The Really Important Questions Current Immunotherapy Trials are Not Answering” at the 14th…
Ronit Simantov, M.D. of Pfizer Oncology presents “Optimizing Therapy of RCC through Industry-Academic Collaborations” at the 14th International Kidney Cancer…
Neeraj Agarwal, MD of Huntsman Cancer Institute, University of Utah presents “Initial therapy for mRCC: High-dose IL-2 or a Checkpoint…
Hans Hammers MD, PhD of Johns Hopkins presents “Initial Therapy for mRCC: Pro: Immune Checkpoint Inhibitors” at the 14th International…
Charles G. Drake MD of Johns Hopkins Kimmel Cancer Center presents Combination Immunotherapeutic Strategies in RCC: Preclinical Rationale AND Clinical…
Gordon Freeman, PhD from the Dana-Farber Cancer Institute Harvard Medical School presents “The Biology of Checkpoint Inhibition” at the 14th…
Moshe C. Ornstein MD MA of the Cleveland Clinic Taussig Cancer Institute presents “Clinical Effect of TKI Dose-Escalation after Disease…
Andrew J. Armstrong MD ScM FACP of Duke Cancer Institute presents “Clinical Trials in Non-Clear Cell RCC” at the 14th…
Jose A. Karam, MD, FACS of MD Anderson presents “RCC with Sarcomatoid Dedifferentiation: New Insights” at the 14th International Kidney…
Gabriel G. Malouf, MD, PhD of Pitie Salpetriere Hospital presents “Collecting Duct Renal Cell Carcinomas” at the 14th International Kidney…
Chad Creighton of Baylor College of Medicine presents “Papillary RCC: The Cancer Genome Atlas (TCGA)” at the 14th International Kidney…
Payal Kapur, M.D. of UT Southwestern Medical Center presents “Chromophobe Renal Cell Carcinoma: TCGA and UTSW Updates’ at the 14th…
Eric Jonasch Professor of Medicine UT MD Anderson Cancer Center presents “VHL Syndrome and Hemangioblastoma Management” at the 14th International…
Paul Russo, MD, FACS of Cornell University presents “Partial Nephrectomy 15 YEARS OF PROGRESS” at the 14th International Kidney Cancer…
Suzanne B. Stewart-Merrill. MD presents ” Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-based Approach” at…
Michael L. Blute Jr,. MD of the University of Wisconsin presents “Novel 3D volume analysis reveals primary tumor diameter is…
Sarah P. Psutka M.D., M.Sc of Cook County, Chicago presents “Management of Local Recurrence After Radical Nephrectomy” at the 14th…
E. Jason Abel, M.D. of the University of Wisconsin presents “Patient Selection for Surgery in RCC with Thrombus” at the…
Dipen J. Parekh, MD of the University of Miami Miller School of Medicine presents “WARMING UP TO ISCHEMIA” at the…
Karim Touijer , MD, MPH from the Memorial Sloan-Kettering Cancer Center presents “Partial Nephrectomy: Does Ischemia Matter?” at the 14th…
James Porter of the Swedish Medical Center Seattle, WA presents “Minimally Invasive Lymphadenectomy for Renal Cell Carcinoma” at the 14th…
Steven C. Campbell, MD, PhD of The Cleveland Clinic discusses “Optimal Treatment of cT1b Renal Mass in Patient with Normal…
Michael A. Gorin, M.D. of Johns Hopkins University School of Medicine discusses “Novel Imaging Techniques in RCC” at the 14th…
Michael Bassetti MD PhD of the University of Wisconsin Madison discusses “University of Wisconsin Madison” at the 14th International Kidney…
R. Houston Thompson, MD Professor of Urology Mayo Clinic discusses “Partial Nephrectomy or Ablation for Small Renal Mass” at the…
Michael A.S. Jewett discusses “Surveillance is the Best Treatment for T1a RCC in a healthy 65 year old patient” at…
Stephen A. Boorjian, MD of the Mayo Clinic, Rochester, MN discusses ” CONTEMPORARY MANAGEMENT OF RENAL ANGIOMYOLIPOMA” at the 14th…
Bradley C. Leibovich, MD, FACS , Mayo Clinic debates ” Renal Mass Biopsy Should Be Used Sparingly in patients with…
Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center debates the Pro side…
A Ari Hakimi MD Memorial Sloan Kettering Cancer Center brings an “Update on Molecular and Genetic Characterization of RCC” at…
Brian R. Lane, M.D., Associate Professor, Michigan State University discusses “Improving Healthcare Delivery in Kidney Cancer” at the 14th International…
Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients…
James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or…
Robert Thomas, MbChb, MRCP, MD, FRCR, gives an overview of the session “Physical activity the panacea?” at the 2015 National…
Prof. Rob Coleman gives an overview of the session “This house believes we should stop focussing on the causes of…